FindTrial
Sign In

comparison of various respiratory medicines in patients with chronic airway disease of prolong duration

A comparative evaluation of safety and efficacy of formoterol with tiotropium bromide and formoterol with glycopyrronium in patients of COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/06/014573
Enrollment
160
Registered
2018-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic obstructive pulmonary disease Health Condition 2: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 3: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Sponsors

Department of pharmacology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with grade II and III COPD in age group of 18 - 65 of both genders will be enrolled in the study

Exclusion criteria

Exclusion criteria: Complicated cases of COPD patients Patients with clinically significant lung disease other than COPD Patients with respiratory failure Patients who are on systemic corticosteroid therapy Pregnant and Lactating patients. Psychotic patients. Critically ill patients. Patients with comorbid conditions like myocardial infarction, diabetes mellitus 5 Known cases of HIV/HBsAg /Anti-HCV and immuno-compromised patients.

Design outcomes

Primary

MeasureTime frame
Pulmonary function testTimepoint: 3 month—

Secondary

MeasureTime frame
safety and cost effectivenessTimepoint: 3 month—

Countries

India

Contacts

Public ContactDr Siraj Ahmad

Jawahar lal nehru medical college and hospital

fahmad32@yahoo.com7417735300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026